-
Research Method, Conduct, and Reporting Considerations for Improving the Quality of Non-Hypothesis-Evaluating Treatment Effectiveness Analyses Using Real-World Data
-
Mapping the Landscape of Open Source Health Economic Models: A Systematic Database Review and Analysis
-
Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions
-
How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health
-
Generative Artificial Intelligence for Health Technology Assessment: Opportunities, Challenges, and Policy Considerations
-
Primer on Health Equity Research in Health Economics and Outcomes Research
-
Good Practices for Health Technology Assessment Guideline Development
-
Recommendations on the Use of Structured Expert Elicitation Protocols for Healthcare Decision Making
-
ISPOR Strategic Plan 2030
-
Assessing Real-World Data From Electronic Health Records for Health Technology Assessment: The SUITABILITY Checklist
-
Mapping Health Technology Assessment Agency Approaches for Biosimilar Value Assessment
-
Systematic Review of Outcomes for Assessment of Medication Adherence Enhancing Interventions
-
Evolving Use of Health Technology Assessment in Medical Device Procurement—Global Systematic Review
-
Recommendations on the Selection, Development, and Modification of Performance Outcome (PerfO) Assessments
-
Quantitative Benefit-Risk Assessment in Medical Product Decision Making
-
A Roadmap for Increasing the Usefulness and Impact of Patient-Preference Studies in Decision Making in Health
-
HARmonized Protocol Template to Enhance Reproducibility of Hypothesis Evaluating Real-World Evidence Studies on Treatment Effects
-
Machine Learning Methods in Health Economics and Outcomes Research—The PALISADE Checklist
-
Designing and Implementing Deliberative Processes for Health Technology Assessment: Joint HTAi/ISPOR Task Force Report
-
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022)
- 1 (current)
- 2
- 3
- 4
- 5
Questions?
For any questions about this report please contact us.